COVID-19

News

Veklury rescues Gilead from COVID doldrums in Q4

Gilead’s COVID-19 drug Veklury (remdesivir) is helping the company through disruption caused by the pandemic and patent expiry on two HIV drugs, according to its

News

Talking vaccines: Industry’s role in protecting the Gavi generation

UK reaches 10 million landmark with COVID-19 vaccination pro...

The UK has reached a major landmark with its COVID-19 vaccination programme, with more than 10 million people receiving their first shot.

Views & Analysis

Not every cough is COVID – MSD UK’s lung cancer campaign

For World Cancer Day, David Long, business unit director of Oncology at MSD UK tells pharmaphorum about the company’s ‘Do It Yourself’ campaign launched in the North East to raise awareness

News

Sputnik V data in Lancet should end “fake news” on its effic...

The publication of data backing Russia’s COVID-19 vaccine Sputnik V in a peer review journal should bring a campaign to discredit the shot to an end, says the head of the Russian Direct Inv

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

Virtual trials and the next generation of pharma clinical re...

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition.

News

AstraZeneca to supply nine million more vaccines to EU

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses.

Veklury rescues Gilead from COVID doldrums in Q4

UK reaches 10 million landmark with COVID-19 vaccination pro...

Not every cough is COVID – MSD UK’s lung cancer campaign

Sputnik V data in Lancet should end “fake news” on its effic...

Virtual trials and the next generation of pharma clinical re...

AstraZeneca to supply nine million more vaccines to EU

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks